Newborn Immunology: Relevance to the Clinician

Current Problems in Pediatric and Adolescent Health Care

Volumn 36, Issue 5, 2006, Pages 189-204

  Lewis, David B ^a   Gern, James E ^b   Hill, Harry R ^c   Friedlander, Samuel L ^b   La Pine, Timothy R ^c   Lemanske Jr , Robert F ^b   Stiehm, E Richard ^d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BCG VACCINE; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; COMPLEMENT; DNA; FAS LIGAND; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPATITIS B VACCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 23; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PLACEBO; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; ANTIBODY RESPONSE; ARTICLE; ASTHMA; BACTERIAL IMMUNITY; BACTERIAL MENINGITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CELLULAR IMMUNITY; COMBINED IMMUNODEFICIENCY; COMPLEMENT DEFICIENCY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DENDRITIC CELL; DNA DETERMINATION; DOMESTIC ANIMAL; ENTEROVIRUS; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HEREDITY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LEUKOCYTE TRANSFUSION; LISTERIA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; NEWBORN CARE; NEWBORN INFECTION; NEWBORN SCREENING; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTE; POLYMERASE CHAIN REACTION; RAT; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SALMONELLA; SENSITIZATION; STREPTOCOCCUS AGALACTIAE; TH1 CELL; TUBERCULOSIS; VIRUS IMMUNITY; VIRUS INFECTION; WHEEZING;

ALLERGY AND IMMUNOLOGY; ANTIBODY FORMATION; ASTHMA; HUMANS; HYPERSENSITIVITY; IMMUNE SYSTEM; IMMUNOGLOBULINS; INFANT, NEWBORN; PHAGOCYTES; T-LYMPHOCYTES;

EID: 33645851323     PISSN: 15385442     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cppeds.2005.11.001     Document Type: Article

References (99)

1. Lewis D.B., and Wilson C.B. Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection. In: Remington J.S., Klein J.O., Baker C., et al. (Eds). Infectious diseases of the fetus and the newborn infant. 6th ed. (2005), Saunders/Elsevier, Philadelphia 87-210
2. Watts C. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat Immunol 5 (2004) 685-692
3. Berenson L.S., Ota N., and Murphy K.M. Issues in T-helper 1 development-resolved and unresolved. Immunol Rev 202 (2004) 157-174
4. Quezada S.A., Jarvinen L.Z., Lind E.F., et al. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 22 (2004) 307-328
5. Frucht D.M., Fukao T., Bogdan C., et al. IFN-gamma production by antigen-presenting cells. mechanisms emerge. Trends Immunol 22 (2001) 556-560
6. Picard C., and Casanova J.L. Inherited disorders of cytokines. Curr Opin Pediatr 16 (2004) 648-658
7. van den Elsen P.J., Holling T.M., Kuipers H.F., et al. Transcriptional regulation of antigen presentation. Curr Opin Immunol 16 (2004) 67-75
8. Wong G.H., and Goeddel D.V. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature 323 (1986) 819-822
9. Seo S.H., Hoffmann E., and Webster R.G. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 8 (2002) 950-954
10. O'Sullivan B., and Thomas R. CD40 and dendritic cell function. Crit Rev Immunol 23 (2003) 83-107
11. Ameratunga R., Lederman H.M., Sullivan K.E., et al. Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome. J Pediatr 131 (1997) 147-150
12. Jain A., Atkinson T.P., Lipsky P.E., et al. Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome. J Clin Invest 103 (1999) 1151-1158
13. Grewal I.S., Borrow P., Pamer E.G., et al. The CD40-CD154 system in anti-infective host defense. Curr Opin Immunol 9 (1997) 491-497
14. Bevan M.J. Helping the CD8+ T-cell response. Nat Rev Immunol 4 (2004) 595-602
15. Catalfamo M., and Henkart P.A. Perforin and the granule exocytosis cytotoxicity pathway. Curr Opin Immunol 15 (2003) 522-527
16. Lee H.O., and Ferguson T.A. Biology of FasL. Cytokine Growth Factor Rev 14 (2003) 325-335
17. Appay V., Dunbar P.R., Callan M., et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8 (2002) 379-385
18. Radosevich T.J., Seregina T., and Link C.J. Effective suppression of class I major histocompatibility complex expression by the US11 or ICP47 genes can be limited by cell type or interferon-gamma exposure. Hum Gene Ther 14 (2003) 1765-1775
19. Mellman I., and Steinman R.M. Dendritic cells. specialized and regulated antigen processing machines. Cell 10 (2001) 255-258
20. Hemmi H., and Akira S. TLR signalling and the function of dendritic cells. Chem Immunol Allergy 86 (2005) 120-135
21. Dabbagh K., Dahl M.E., Stepick-Biek P., et al. Toll-like receptor 4 is required for optimal development of Th2 immune responses. role of dendritic cells. J Immunol 168 (2002) 4524-4530
22. Housset D., and Malissen B. What do TCR-pMHC crystal structures teach us about MHC restriction and alloreactivity?. Trends Immunol 24 (2003) 429-437
23. Chen L., Cohen A.C., and Lewis D.B. Impaired allogeneic activation and T-helper 1 differentiation of human cord blood naive CD4 T cells. Biol Blood Marrow Transplant 12 (2006) 160-171
24. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3 (2003) 133-146
25. Kaminski B.A., Kadereit S., Miller R.E., et al. Reduced expression of NFAT-associated genes in UCB versus adult CD4+ T lymphocytes during primary stimulation. Blood 102 (2003) 4608-4617
26. West D.J. Clinical experience with hepatitis B vaccines. Am J Infect Control 17 (1989) 172-180
27. Whitley R.J. Herpes simplex virus infections of women and their offspring. implications for a developed society. Proc Natl Acad Sci USA 91 (1994) 2441-2447
28. Kimberlin D.W. Neonatal herpes simplex infection. Clin Microbiol Rev 17 (2004) 1-13
29. Herget G.W., Riede U.N., Schmitt-Graff A., et al. Generalized herpes simplex virus infection in an immunocompromised patient-report of a case and review of the literature. Pathol Res Pract 201 (2005) 123-129
30. Burchett S.K., Weaver W.M., Westall J.A., et al. Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes. J Immunol 140 (1988) 3473-3481
31. Sullender W.M., Miller J.L., Yasukawa L.L., et al. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J Infect Dis 155 (1987) 28-37
32. Tu W., Chen S., Sharp M., et al. Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J Immunol 172 (2004) 3260-3267
33. Chen S.F., Tu W.W., Sharp M.A., et al. Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood. J Infect Dis 189 (2004) 1619-1627
34. Stagno S. Cytomegalovirus. In: Remington J.S., and Klein J.O. (Eds). Infectious diseases of the fetus and newborn infant. 5th ed. (2001), W.B. Saunders, Philadelphia 389-424
35. Marchant A., Appay V., Van Der Sande M., et al. Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest 111 (2003) 1747-1755
36. Cherry J.D. Enteroviruses. In: Remington J.S., Klein J.O., Baker C., et al. (Eds). Infectious diseases of the fetus and newborn. 5th ed. (2001), W.B. Saunders, Philadelphia 477-518
37. Lin T.Y., Kao H.T., Hsieh S.H., et al. Neonatal enterovirus infections. emphasis on risk factors of severe and fatal infections. Pediatr Infect Dis J 22 (2003) 889-894
38. Remington J.S., McLeod R., Thulliez P., et al. Toxoplasmosis. In: Remington J.S., and Klein J.O. (Eds). Infectious diseases of the fetus and newborn infant. 5th ed. (2001), W.B. Saunders, Philadelphia 205-346
39. de Repentigny L., Lewandowski D., and Jolicoeur P. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin Microbiol Rev 17 (2004) 729-759
40. Smith S., Jacobs R.F., and Wilson C.B. The immunobiology of childhood tuberculosis. a window on the ontogeny of cellular immunity. J Pediatr 131 (1997) 16-26
41. Marchant A., Goetghebuer T., Ota M.O., et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol 163 (1999) 2249-2255
42. Vekemans J., Amedei A., Ota M.O., et al. Neonatal bacillus Calmette-Guerin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol 3 (2001) 1531-1535
43. Jones J.M., and Gellert M. The taming of a transposon. V(D)J recombination and the immune system. Immunol Rev 200 (2004) 233-248
44. Hazenberg M.D., Verschuren M.C., Hamann D., et al. T cell receptor excision circles as markers for recent thymic emigrants. basic aspects, technical approach, and guidelines for interpretation. J Mol Med 79 (2001) 631-640
45. Chan K., and Puck J.M. Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol 115 (2005) 391-398
46. McGhee S.A., Stiehm E.R., and McCabe E.R.B. Potential costs and benefits of newborn screening for severe combined immunodeficiency. J Pediatr 147 (2005) 603-608
47. Lewis D.B., Larsen A., and Wilson C.B. Reduced interferon-gamma mRNA levels in human neonates. Evidence for an intrinsic T cell deficiency independent of other genes involved in T cell activation. J Exp Med 163 (1986) 1018-1023
48. Prescott S.L., Macaubas C., Holt B.J., et al. Transplacental priming of the human immune system to environmental allergens. universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 160 (1998) 4730-4737
49. Halonen M., and Martinez F.D. A deficient capacity to produce interferon-gamma. is it a risk for asthma and allergies?. Clin Exp Allergy 27 (1997) 1234-1236
50. Prescott S.L. Early origins of allergic disease. a review of processes and influences during early immune development. Curr Opin Allergy Clin Immunol 3 (2003) 125-132
51. Tang M.L.K., Kemp A.S., Thorburn J., et al. Reduced interferon-γ production in neonates and subsequent atopy. Lancet 344 (1994) 983-985
52. Miles E.A., Warner J.A., Jones A.C., et al. Peripheral blood mononuclear cell proliferative responses in the first year of life in babies born to allergic parents. Clin Exp Allergy 2 (1996) 780-788
53. Williams T.J., Jones C.A., Miles E.A., et al. Fetal and neonatal IL-13 production during pregnancy and at birth and subsequent development of atopic symptoms. J Allergy Clin Immunol 105 (2000) 951-959
54. van der Pouw Kraan T.C.T.M., Boeije L.C.M., de Groot E.R., et al. Reduced production of IL-12 and IL-12-dependent IFN-g release in patients with allergic asthma. J Immunol 158 (1997) 5560-5565
55. Koning H., Neijens H.J., Baert M.R., et al. T cell subsets and cytokines in allergic and non-allergic children. I. Analysis of IL-4, IFN-gamma and IL-13 mRNA expression and protein production. Cytokine 9 (1997) 416-426
56. Nakao F., Ihara K., Kusuhara K., et al. Association of IFN-gamma and IFN regulatory factor 1 polymorphisms with childhood atopic asthma. J Allergy Clin Immunol 107 (2001) 499-504
57. Rowe J., Heaton T., Kusel M., et al. High IFN-gamma production by CD8+ T cells and early sensitization among infants at high risk of atopy. J Allergy Clin Immunol 113 (2004) 710-716
58. Lemanske Jr. R.F. The childhood origins of asthma (COAST) study. Pediatr Allergy Immunol 13 Suppl 15 (2002) 38-43
59. Neaville W.A., Tisler C., Anklam K., et al. Developmental cytokine response profiles and the clinical and immunologic expression of atopy in infancy. J Allergy Clin Immunol 112 (2003) 740-746
60. Gern J.E., Martin M.S., Anklam K.A., et al. Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy. Pediatr Allergy Immunol 13 (2002) 386-393
61. Hoffjan S., Ostrovnaja I., Nicolae D., et al. Genetic variation in immunoregulatory pathways and atopic phenotypes in infancy. J Allergy Clin Immunol 113 (2003) 511-518
62. Strachan D.P. Hay fever, hygiene, and household size. BMJ 299 (1989) 1259-1260
63. Bufford J.D., and Gern J.E. The hygiene hypothesis revisited. Immunol Allergy Clin North Am 25 (2005) 247-262
64. Lemanske Jr. R.F., Jackson D.J., Gangnon R.E., et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 116 (2005) 571-577
65. Copenhaver C.C., Gern J.E., Li Z., et al. Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir Crit Care Med 170 (2004) 175-180
66. Gern J.E., Reardon C.L., Hoffjan S., et al. Effects of dog ownership and genotype on immune development and atopy in infancy. J Allergy Clin Immunol 113 (2004) 307-314
67. Hemming V.G., Hall R.T., Rhodes P.G., et al. Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence. J Clin Invest 58 (1976) 1379-1387
68. Shigeoka A.O., Hall R.T., and Hill H.R. Blood-transfusion in group B streptococcal sepsis. Lancet 1 (1978) 636-638
69. Santos J.I., Shigeoka A.O., Rote N.S., et al. Protective efficacy of a modified immune serum globulin in experimental group B streptococcal infection. J Pediatr 99 (1981) 873-879
70. Christensen R.D., Hardman T., Thornton J., et al. A randomized, double-blind placebo-controlled investigation of the safety of intravenous immune globulin administration to preterm neonates. J Perinatol 9 (1989) 126-130
71. Hill H.R., Shigeoka A.O., Pincus S., et al. Intravenous IgG in combination with other modalities in the treatment of neonatal infections. Pediatr Infect Dis J 5 (1986) S180-S184
72. Hill H.R., Yang K.D., Shigeoka A.O., et al. Intravenous immunoglobulin use in newborns. Clin Immunol Allergy 84 (1989) 617-624
73. Hill H.R. Intravenous immunoglobulin use in the neonate. role in prophylaxis and therapy of infection. Pediatr Infect Dis J 12 (1993) 549-559
74. Hill H.R. Additional confirmation of the lack of effect of intravenous immunoglobulin in the prevention of neonatal infection. J Pediatr 137 (2000) 595-597
75. Jenson H.B., and Pollock B.H. Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis. Pediatrics 99 2 (1997) E2
76. Kim K.S. Efficacy of human immunoglobulin and penicillin G in treatment of group B streptococcal infection. Pediatr Res 21 (1987) 289-292
77. Christensen R.D., and Rothstein G. Exhaustion of mature marrow neutrophils in neonates with sepsis. J Pediatr 96 (1980) 316-318
78. Christensen R.D., Shigeoka A.O., Hill H.R., et al. Neutropenia and bone marrow exhaustion in human and experimental neonatal sepsis. Pediatr Res 14 (1980) 806-808
79. Christensen R.D., MacFarlane J.L., Taylor N.L., et al. Blood and marrow neutrophils during experimental group B streptococcal infection. quantification of the stem cell, proliferative, storage and circulating pools. Pediatr Res 16 (1982) 549-553
80. Laurenti F., Ferro R., Isacchi G., et al. Polymorphonuclear leukocyte transfusion for the treatment of sepsis in the newborn infant. J Pediatr 98 (1981) 118
81. Christensen R.D., Rothstein G., Bradley P., et al. Granulocyte transfusions increase survival in neonates with sepsis and neutrophil depletion. Pediatr Res 15 (1981) 608
82. Hill H.R. Phagocyte transfusion-ultimate therapy of neonatal disease?. J Pediatr 98 (1981) 59-61
83. Hill H.R. Granulocyte transfusions in neonates. Pediatr Rev 12 (1991) 298-302
84. Cairo M.S., Worcester C.V.C., Rucker R.W., et al. Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for a neonatal neutropenia and sepsis. J Pediatr 120 (1992) 281-285
85. Christensen R.D., Brown M.S., Hall D.C., et al. Effect of IVIG administration to neonates with clinical signs of early-onset sepsis on neutrophil kinetics and serum opsonic capacity. J Pediatr 118 (1991) 606-614
86. Shigeoka A.O., Gobel R.J., Janatova J., et al. Neutrophil mobilization induced by complement fragments during experimental group B streptococcal infection. Am J Pathol 33 (1988) 623-629
87. Hill H.R., Gonzales L.A., Knappe W.A., et al. Comparative protective activity of human monoclonal and hyperimmune polyclonal antibody against group B streptococci. J Infect Dis 163 (1991) 792-798
88. Shyur S.D., Raff H.V., Bohnsack J.F., et al. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci. J Immunol 148 (1992) 1879-1884
89. Schibler K.R., Liechty K.W., White W.L., et al. Production of granulocyte colony-stimulating factor in vitro by monocytes from preterm and term neonates. Blood 82 (1993) 2478-2484
90. Bernstein H.M., Calhoun D.A., and Christensen R.D. Use of myeloid colony-stimulating factors in neonates with septicemia. Curr Opin Pediatr 14 (2002) 91-94
91. Carr R., Modi N., and Dore C. G-CSF and GM-CSF for treating or preventing neonatal infections. Vol. 1. The Cochrane Library (2005), John Wiley & Sons, Ltd, New York 1-30.
92. Bryson Y.J., Winter H.S., Gard S.E., et al. Deficiency of immune interferon production by leukocytes of normal newborns. Cell Immunol 55 (1980) 191-200
93. Lewis D.B., Larsen A., and Wilson C.B. Reduced interferon-γmRNA levels in human neonates. Evidence for an intrinsic T cell deficiency independent of other genes involved in T cell activation. J Exp Med 163 (1986) 1018-1023
94. Lewis D.B., Weaver M., Prickett K., et al. Restricted production of IL4 compared to IFN-gamma by human T cells during postnatal development. J Cell Biochem 13 A (1989) 233
95. Joyner J.L., Augustine N.A., La Pine T.R., et al. Effects of group B streptococci on cord and adult mononuclear cell transcription and translation of IL-12 and IFN-γ. J Infect Dis 182 (2000) 974-977
96. La Pine T.R., Joyner J.L., Augustine N.H., et al. Defective production of IL-18 and IL-12 by cord blood mononuclear cells influences the T helper-1 interferon gamma response to group B streptococci. Pediatr Res 54 (2003) 276-281
97. Hill H.R., Augustine N.H., and Jaffe H.S. Human recombinant interferon gamma enhances neonatal PMN activation and movement and increases free intracellular calcium. J Exp Med 173 (1991) 767-770
98. La Pine T.R., Wiest D.J., Augustine N.H., et al. T-helper-1 cytokines and neutrophil function in neonatal host defense. J Invest Med 53 (2005) S153
99. La Pine T.R., Wiest D.J., Augustine N.H., et al. T-helper-1 cytokines and neutrophil function in neonatal host defense. PAS Progr Abstr 57 (2005) 156